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Type II hypozincemia of infancy is a rare, hereditary zinc deﬁciency occurring in infants while exclu-
sively on breast feeding. It is caused by defective transfer of zinc into breast milk. Only a few dozen
cases have been reported. A 6-month-old, full-term, breast-fed female infant presented with a 3-week
history of erythematous to dusky red papules and annular plaques over the perioral and diaper area as
well as the digits. The eruption was accompanied by poor appetite and irritable crying. Serum zinc was
low (4.896 mmol/L, normal ¼ 10.7118.36 mmol/L) in the patient but was normal in the mother.
Interestingly, the zinc level in the breast milk was very low (2.142 mmol/L; normal postpartum zinc ¼
18.36 mmol/L at 6 months). Histopathology of a skin biopsy specimen showed spongiotic psoriasiform
dermatitis with pallor of superﬁcial keratinocytes, consistent with deﬁciency disease. With oral zinc
sulfate supplement, her skin lesions improved signiﬁcantly within 4 days. Type II hypozincemia needs
to be differentiated from the classical hereditary acrodermatitis enteropathica, which typically
develops symptoms after weaning because of poor intestinal absorption of zinc in the affected infants.
Mutations in zinc transporter genes have been detected in SLC39A4 (Zip4) and SLC30A2 (ZnT2),
respectively, in classical acrodermatitis enteropathica and type II hypozincemia. No mutation was
found in these two genes in the present pedigree. Therefore, the genetic defect in our patient might
involve other zinc transporter genes.
Copyright  2012, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Zinc is an important trace nutrient required for proper functions of
more than 100 enzymes and plays a crucial role in nucleic acid
metabolism.1 Patients with zinc deﬁciency typically manifest
acrodermatitis enteropathica (AE)-like features characterized by
erythematous, scaly and crusted lesions with vesicles, pustules and
erosions predominantly affecting the extremities as well as the
diaper and perioriﬁcial areas. Populations at risk of zinc deﬁciency
include patients with intestinal malabsorption syndrome, liver
disease, anorexia nervosa or food faddism, extensive cutaneous
burns and nephrotic syndrome. In addition, zinc deﬁciency can be
caused by genetic defects in absorption or secretion of zinc in the
body.2 There are three types of zinc deﬁciency in infancy.3 Type I isent of Dermatology, National
Tainan, Taiwan. Tel.: þ886 6
e).
iwanese Dermatological Associatiocharacterized by an inherent defect in absorption of zinc from the
gut, i.e., the classical AE. The disease onset is typically when
weaning from breast milk to formula or cereal, which have lower
zinc bioavailability than breast milk.2 Type II is caused by defective
transfer of zinc into the mother’s milk. In contrast to the classical
AE, the symptoms develop in infants during breast feeding but
improve after weaning to formula or table foods. Type III develops
in preterm infants who are put on prolonged parenteral alimenta-
tion deﬁcient in zinc.3 All three types manifest similar skin lesions
clinically. Herein, we report a case of type II hypozincemia in
a breast-fed infant, and discuss the genetic defect and mechanism
of zinc deﬁciency.Case presentation
A 6-month-old, full-term, breast-fed female infant presented with
a 3-week history of multiple erythematous to dusky red, scaly or
crusted papules and annular plaques over the perioral and diapern. Published by Elsevier Taiwan LLC. All rights reserved.
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accompanied by poor appetite and irritable crying, but no diarrhea.
The patient was the ﬁrst born to the unrelated, healthy parents and
there was no family history of zinc deﬁciency. Histopathological
examination of a skin biopsy specimen from the diaper area
revealed spongiotic psoriasiform hyperplasia of the epidermis with
pallor of the superﬁcial keratinocytes (Figure 2). The papillary
dermis was slightly edematous with a moderately dense peri-
vascular inﬁltrate of small lymphocytes. The pathological ﬁndings
were consistent with deﬁciency disease.
Blood from the patient and her mother and a fresh breast milk
sample were obtained in zinc-free vacutainer tubes and sent to our
Hospital Lab immediately. All samples were diluted with deionized
water (1:5 dilution) and then centrifuged. Zinc content from the
supernatant was measured by atomic absorption spectroscopy
(Perkin-Elmer 5100, Waltham, Massachusetts, USA). Decreased
serum zinc level (4.896 mmol/L, normal ¼ 10.7118.36 mmol/L) was
detected. Alkaline phosphatase level was also decreased (104 U/L,
normal ¼ 150e420 U/L in infants). The zinc level in the maternal
serum was normal (12.85 mmol/L), but in the breast milk was very
low (2.142 mmol/L; normal postpartum zinc ¼ 61.2 mmol/L at
2 weeks, 18.36 mmol/L at 6 months).4 For comparison, a sample of
breast milk from a mother with a healthy, full-term 3-month-old
infant was checked and the zinc level was 24.94 mmol/L (serum zinc
of that mother was not checked).
With oral zinc sulfate supplement (element zinc 3 mg/kg/day),
the patient’s skin lesions improved signiﬁcantly in 4 days, and
resolved completely in 25 days (Figure 3). At that time the serum
zinc was found to be 21.42 mmol/L and alkaline phosphatase level
was 320 U/L. The zinc supplement was discontinued and there was
no recurrence afterwards. We did mutation analysis of SLC39A4
and SLC30A2 genes by direct DNA sequencing using the genomic
DNA extracted from the peripheral blood of the patient and her
mother. No mutation was detected.Figure 1 A 6-month-old, breast-fed full-term Taiwanese female infant presents with multi
perioral area (A), diaper area (B) and digits (C) for a 3-week duration.One year later, the parents brought in their second baby, a 5-
month-old boy, with erythematous and focally scaly lesions with
desquamation over the perioral and diaper areas. The baby boy was
fed with breast milk exclusively. Because of the earlier experience,
the parents sought our attention within days after onset of the skin
lesions. The boy’s serum zinc was very low (3.06 mmol/L), and the
zinc in the breast milk collected at the same time was also very low
(1.07 mmol/L). The skin lesions responded quickly to zinc supple-
ment. We advised the parents to start other food supplements
additionally instead of feeding the baby only with breast milk.
Discussion
Zinc deﬁciency in humans is mostly caused by dietary deﬁciency.
However, transient, symptomatic zinc deﬁciency caused by inade-
quate zinc contents in breast milk has been reported in breast-fed
babies.3,5e21 Sharma et al22 described this condition in an Indian
pedigree with 10 affected children in three interrelated families
(Families 1, 2 and 3), in which the three fathers were brothers from
family A and the three mothers (two sisters and the third one was
an aunt to the two sisters) were from family B. The disease had its
onset before weaning and disappeared when the affected children
started a normal solid diet. Eleven babies of these three couples
survived the age of 3 months, which was the age of onset of
symptoms, and 10 of them had been afﬂicted with the disease. One
girl escaped the disease because she was fed cow’s milk after
3 months of age. For other members of Families A and B without
consanguineous marriage, there was no affected offspring. The
pedigree and consanguinity suggested an autosomal recessive
inheritance.22
Type II hypozincemia appears to be rare, but the incidence in the
general population is unknown. In the previously reported cases
where more detailed information was available, 21 of 37 patients
were preterm and 11 of 37 patients were term infants (Table 1).ple erythematous to dusky red, scaly or crusted papules and annular plaques over the
Figure 2 (A) Histopathological examination of a skin lesion reveals spongiotic psoriasiform hyperplasia with pallor of the superﬁcial keratinocytes, covered by a thick conﬂuent
layer of parakeratosis containing plasma globules. The papillary dermis is slightly edematous with a moderately dense perivascular inﬁltrate of small lymphocytes. (B) A close-up
view of the conﬂuent parakeratosis and hypogranulosis.
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diarrhea or irritability. Clinical symptoms or signs improved
dramatically after days to weeks of zinc supplement. Our patient
was a full-term baby and had disease onset while on breast feeding.
The clinical and pathological ﬁndings as well as low to very low zinc
levels in the patient’s serum and the mother’s breast milk sup-
ported the diagnosis of type II hypozincemia of infancy in our
patient. Type II hypozincemia differs from the classical AE in several
aspects.23 The differences are summarized in Table 2.
The functions of zinc have been grouped into three categories:
catalytic, structural and regulatory.4 Zinc is an essential component
of the catalytic site of hundreds of different metalloenzymes,
including carbonic anhydrase, alkaline phosphatase, RNA poly-
merases, etc. Zinc is also an important structural component of
gene regulatory proteins and facilitates appropriate protein folding.
The third function of zinc is regulation. For example, zinc acts as an
ionic signal in cells moving through gated membrane channels.
“Gluzinergic” means zinc selectively stored in and released from
neurons in the cerebral cortex that also release glutamate.4
Adequate zinc levels are crucial for wound healing, immune
response and neurological function.2 Patients with zinc deﬁciency
present with eczematous scaly plaques which can become vesic-
ular, bullous, pustular or desquamative. The lesions typically affect
the extremities, and diaper and perioriﬁcial areas.4 Patients are also
predisposed to systemic infections and superinfectionwith Candida
albicans and bacteria, usually Staphylococcus aureus. Diarrhea may
be prominent but is not seen in all cases. More prolonged deﬁciency
may result in growth impairment and neuropsychological changesFigure 3 After the supplement with oral zinc sulfate for 25 days, her skin lesuch as emotional instability, irritability and depression.23 If
untreated, the disease is fatal.2 Zinc supplement should be started
and clinical improvement is seen very rapidly, within days to
weeks. In zinc-deﬁciency states such as classical AE or transient
infantile zinc deﬁciency, zinc supplement should be started at
2e3 mg/kg/day of elemental zinc.4,5 In patients with zinc
deﬁciency caused by low dietary zinc, treatment with elemental
zinc supplementation, 0.5e1 mg/kg/day is recommended.4 In
malnourished patients, a multinutrient replacement approach is
warranted.
Zinc homeostasis depends on adequate zinc absorption and
maintenance of appropriate intracellular and extracellular zinc
levels. Dietary sources of zinc include meat, ﬁsh, shellﬁsh, eggs and
dairy products. Most vegetables, fruits and reﬁned carbohydrates
contain very little zinc. Moreover, phytates (found in cereal grains,
legumes and nuts) and ﬁbers interfere with intestinal zinc
absorption.2 Human breast milk contains very high levels of zinc
during the ﬁrst 1 to 2months of lactation.2 Themammary gland can
secret an extraordinary amount of zinc into milk during lactation.
The zinc concentration in the breast milk is maintained over a wide
range of dietary zinc intake, which suggests that the import and
export of zinc by the mammary gland are tightly regulated.
Impairments in this process can result in severe zinc deﬁciency in
breast-fed infants.24 It has been shown that oral supplementation
of zinc to human mothers with low zinc content of their milk did
not lead to an increase of zinc in the milk.25,26
Zinc transporters are transmembrane proteins. There are two
families of mammalian zinc transporters. The ﬁrst is the ZnT familysions including perioral area (A) and diaper area (B) resolve completely.
Table 1 Summary of reports cases of transient infantile zinc deﬁciency.
Ref. Case no. Birth history Clinical Feeding Infant zinca ALKP Maternal zinca Breast milk zinca
2 1 d D, GI, Irritable BF Y(6.89) Y d Y
5 1 Preterm D BF Y(6.12) d Normal Y(3.06)
6 1 Preterm D, GI, Hair BF Y(2.49) Y(128) Normal Y(2.10)
7 10 9 preterm D BF (fortiﬁer) Y(2.49w8.68) d 6.36e11.78 Y(2.49w4.97)
1 term
8 2 2 term D, Hair BF Y; d d Normal Y(3.98; 3.52)
9 1 Preterm D, GI, Irritable BF Y(2.98) d d d
10 1 Preterm D, GI BF Y(5.66) d d d
11 1 d D BF Y d Normal Y
12 2 Preterm D BF Y d Normal Y
13 2 Preterm D BF Y d d Y
1 term
14 1 Preterm D, GI, Irritable BF Y d d Y
15 1 Preterm D, Hair, Irritable BF Y(2.29) Y d Y(5.66)
16 1 Term D, GI BF Y d d Y
17 2 1 preterm D, GI BF Y(2.45; 3.06) d Normal Borderline low;Y
1 term
18 2 1 term D BF Y d d Y
1d
19 2 2 term D BF Y d SlightlyY Y
20 1 Term D BF Y d d Y
21 1 Preterm D BF Y d d Y
30 1 Preterm D BF Y d d Y
31 2 Preterm D BF Y(3.58; 4.77) d d Y(2.29; 3.18)
Our case 1 Term D, Irritable BF Y(4.90) Y(104) 12.85 Y(2.14)
a mmol/L, serum zinc normal range ¼ 10.7118.36 mmol/L.
ALKP ¼ alkaline phosphatase; BF ¼ breast feeding; case no. ¼ case number; D ¼ dermatologic symptoms; GI ¼ gastrointestinal symptoms; Hair ¼ alopecia; Ref. ¼ reference;
d ¼ no data.
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level by transporting zinc from the cytoplasm to the lumen of
organelles or the extracellular space. The second is the ZIP family
(encoded by SLC39), which increases intracellular zinc levels by
promoting zinc inﬂux into cells or zinc release from intracellular
vesicles.4 Human zinc transporters are designated SLC30A or
SLC39A. Ten ZnT transporters and 14 Zip transporters have been
identiﬁed thus far.4,27
Mutations have been detected in SLC39A4 (encoding Zip4) in
some of the pedigrees with AE.25,28,29 In type II hypozincemia,
a missense mutation has been identiﬁed in SLC30A2 (encoding
ZnT2) in two infants from two mothers with low milk zinc
concentration resulting in transient neonatal zinc deﬁciency in
a pedigree.8 In our patient, mutation analysis of both SLC30A2 and
SLC39A4 genes was performed but no mutation was found. Thus,
the genetic defect in our patient may involve other zinc transporter
genes and needs to be further investigated.
In summary, we presented a Taiwanese infant with type II
hypozincemia, which should be differentiated from classical AE
because of the difference in treatment and prognosis. As breast
feeding and delayed weaning are becoming more common in
Taiwan and other parts of the world, it is important to be aware of
this type of infantile hypozincemia so that early diagnosis can beTable 2 Comparison of type I and type II hypozincemia of infancy.
Type I hypozincemia
(acrodermatitis enteropathica)
Type II hypozincemia
Incidence Rare, 1/500,000 Unknown
Onset During weaning from breast milk
to formula or cereal. Mother milk
has protective role
During breast feeding and
improves after weaning to
formula or table food
Mechanism Defect of zinc absorption in the gut Defect of zinc secretion into the
breast milk
Mutations
found
SLC39A4, encoding Zip4 SLC30A2, encoding ZnT2
Treatment Life-long zinc supplement Short-term zinc supplementestablished and prolonged morbidity and complications can be
prevented in these infants.
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